| Human pancreatic alpha amylase in complex with peptide inhibitor piHA-L5(d10Y) | |
Heteromer
| 16-511 | 1×CL; 1×CA; |
| Assess |
| Ultra High Resolution Crystal Structure of Human Pancreatic Alpha Amylase | | monomer | 16-511 | 1×NAG; 1×CL; 1×CA; |
| Assess |
| Wild-Type Human Pancreatic Alpha-Amylase at True Atomic Resolution (1.07 A) | | monomer | 16-511 | 1×CL; 1×CA; |
| Assess |
| Montbretin A analogue M06-MbA in complex with Human pancreatic alpha-amylase | | monomer | 16-511 | 1×NAG; 1×ZXY; 1×CL; 1×CA; |
| Assess |
| Human Pancreatic alpha-amylase in complex with myricetin | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; 1×MYC; |
| Assess |
| Human Pancreatic Alpha-Amylase in complex with the mechanism based inactivator glucosyl epi-cycloph… | | monomer | 16-511 | 1×5QP; 1×CL; 1×CA; |
| Assess |
| Montbretin A analogue M10-MbA in complex with Human pancreatic alpha-amylase | | monomer | 16-511 | 1×CL; 1×CA; 1×ZXU; 1×MPD; 1×NAG; |
| Assess |
| Human pancreatic alpha-amylase with bound ethyl caffeate | | monomer | 16-511 | 1×NAG; 3×0XR; 1×CL; 1×CA; |
| Assess |
| Human pancreatic alpha-amylase in complex with montbretin A | | monomer | 16-511 | 1×CA; 1×CL; 1×3L9; |
| Assess |
| Human pancreatic alpha-amylase in complex with mini-montbretin A | | monomer | 16-511 | 1×5J7; 1×CA; 1×CL; |
| Assess |
| Alpha-Amylase in complex with probe fragments | | monomer | 16-511 | 4×GLC; 1×GLC; 1×CA; 1×CL; |
| Assess |
| Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic … | | monomer | 16-511 | 3×B0D; 1×B9D; 1×CA; 1×CL; |
| Assess |
| The structure of human pancreatic alpha-amylase at 1.8 angstroms resolution and comparisons with re… | | monomer | 16-511 | 1×CA; 1×CL; |
| Assess |
| Selective and potent inhibition of the glycosidase human amylase by the short and extremely compact… | | monomer | 16-511 | 1×CL; 1×CA; |
| Assess |
| Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic … | | monomer | 16-511 | 1×B9D; 2×B0D; 1×CA; 1×CL; |
| Assess |
| Human Pancreatic Alpha Amylase with Bound Nitrate | | monomer | 16-511 | 1×NAG; 1×NO3; 1×CA; |
| Assess |
| In situ extension as an approach for identifying novel alpha-amylase inhibitors, structure containi… | | monomer | 16-511 | 1×NAG; 1×LAG; 1×CA; 1×CL; 1×GOX; |
| Assess |
| N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Azide | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; 2×AZI; 3×NA; |
| Assess |
| Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic… | | monomer | 16-511 | 1×BGC; 1×CA; 1×CL; 1×NAG; |
| Assess |
| Mechanistic Analyses of Catalysis in Human Pancreatic alpha-Amylase: Detailed Kinetic and Structura… | | monomer | 16-511 | 1×CA; 1×CL; |
| Assess |
| Mechanistic Analyses of Catalysis in Human Pancreatic Alpha-Amylase: Detailed Kinetic and Structura… | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; |
| Assess |
| N298S mutant of Human Pancreatic Alpha-Amylase in complex with nitrate | | monomer | 16-511 | 1×NAG; 1×CA; 1×NO3; |
| Assess |
| In situ extension as an approach for identifying novel alpha-amylase inhibitors, structure containi… | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; 1×GOX; |
| Assess |
| In situ extension as an approach for identifying novel alpha-amylase inhibitors | | monomer | 16-511 | 1×NAG; 1×LM2; 1×CA; 1×CL; |
| Assess |
| Human pancreatic alpha-amylase complexed with nitrite and acarbose | | monomer | 16-511 | 1×NAG; 1×CA; 1×NO2; 1×QV4; |
| Assess |
| N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose | | monomer | 16-511 | 1×NAG; 1×ARE; 1×CA; 1×NO3; |
| Assess |
| SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACO… | | monomer | 16-511 | 1×GLC; 1×GLC; 1×NAG; 1×CA; 1×CL; 1×HMC; |
| Assess |
| SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACO… | | monomer | 16-511 | 1×GLC; 1×CA; 1×CL; |
| Assess |
| SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACO… | | monomer | 16-511 | 1×CA; 1×CL; |
| Assess |
| Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic … | | monomer | 16-511 | 1×B9D; 1×GLF; 1×CA; 1×CL; |
| Assess |
| Structure of the N298S variant of human pancreatic alpha-amylase complexed with acarbose | | monomer | 16-511 | 1×NAG; 1×AAO; |
| Assess |
| Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic… | | monomer | 16-511 | 1×NAG; 1×ARE; 1×CA; 1×CL; |
| Assess |
| Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic… | | monomer | 16-511 | 1×GLC; 1×CA; 1×CL; 1×NAG; |
| Assess |
| Human pancreatic alpha-amylase complexed with azide | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; 2×AZI; 3×NA; |
| Assess |
| Structure of the N298S variant of human pancreatic alpha-amylase | | monomer | 16-511 | 1×NAG; 1×CA; |
| Assess |
| THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337A VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE | | monomer | 16-511 | 1×CA; |
| Assess |
| Three Dimensional Structure Analysis of the R195Q Variant of Human Pancreatic Alpha Amylase | | monomer | 16-511 | 1×NAG; 1×CA; |
| Assess |
| HUMAN PANCREATIC ALPHA-AMYLASE FROM PICHIA PASTORIS, GLYCOSYLATED PROTEIN | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; |
| Assess |
| Structure of the N298S variant of human pancreatic alpha-amylase complexed with chloride | | monomer | 16-511 | 1×NAG; 1×CA; 1×CL; |
| Assess |
| Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose | | monomer | 16-511 | 1×NAG; 1×ARE; 1×NO3; 1×CA; |
| Assess |
| THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337Q VARIANT OF HUMAN PANCREATIC ALPHA-MYLASE | | monomer | 16-511 | 1×NAG; 1×CA; |
| Assess |
| Three Dimensional Structure Analysis of the R195A Variant of Human Pancreatic Alpha Amylase | | monomer | 16-511 | 1×NAG; 1×CA; |
| Assess |
| Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic… | | monomer | 16-511 | 1×NAG; 1×6SA; 1×CA; 1×CL; |
| Assess |
| Structure of the N298S variant of human pancreatic alpha-amylase complexed with chloride and acarbo… | | monomer | 16-511 | 1×NAG; 1×ARE; 1×CA; 1×CL; |
| Assess |
| Starch binding sites on the Human pancreatic alpha amylase D300N variant complexed with an octaose … | | monomer | 16-511 | 2×GLC; 2×GLC; 1×GLC; 1×CL; 1×CA; |
| Assess |
| Human pancreatic alpha-amylase complexed with nitrite | | monomer | 16-511 | 1×NAG; 1×CA; 1×NO2; |
| Assess |
| STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE CARBOHYDRATE INHIBITOR ACARBOSE | | monomer | 16-511 | 1×BGC; 1×CL; 1×CA; |
| Assess |
| Structures of human pancreatic alpha-amylase in complex with acarviostatin IV03 | | monomer | 17-511 | 1×GLC; 1×GLC; 1×GLC; 1×GLC; 1×CA; 1×CL; 1×SO4; 2×HSD; 1×PCA; 1×BGC; 2×MPD; |
| Assess |
| Structures of human pancreatic alpha-amylase in complex with acarviostatin II03 | | monomer | 17-511 | 1×GLC; 1×GLC; 1×GLC; 1×BGC; 1×CA; 1×CL; 1×SO4; 1×NAG; 2×ACI; 1×PCA; 1×MPD; |
| Assess |
| Crystal structure of alpha-amylase in complex with acarviostatin I03 | | monomer | 17-511 | 1×GLC; 1×GLC; 1×GLC; 1×BGC; 1×CA; 1×CL; 1×SO4; 1×NAG; 1×ACI; 1×PCA; 1×MPD; |
| Assess |
| Structures of human pancreatic alpha-amylase in complex with acarviostatin III03 | | monomer | 17-511 | 1×GLC; 1×BGC; 1×BGC; 1×BGC; 1×CA; 1×CL; 1×SO4; 2×HSD; 1×PCA; 1×GLC; |
| Assess |